NuSirt takes in $6 mln Series C
Nashville-based NuSirt Biopharma, which focuses on helping people with chronic metabolic diseases, has secured $6 million in Series C funding. The investors included Hatteras Venture Partners, Mountain Group Partners and TriStar Technology Ventures.
14 May 2015•3 mins read
